Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Description

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Conditions

Small Cell Lung Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Rapid ("Warm") Autopsy Protocol for Patients With Small Cell Lung Cancer

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Condition
Small Cell Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States, 46202

Indianapolis

Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States, 46202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. ≥ 18 years old at the time of informed consent
  • 2. Written informed consent and HIPAA authorization for release of personal health information.
  • 3. Active SCLC diagnosis.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Indiana University,

Shadia I. Jalal, MD, PRINCIPAL_INVESTIGATOR, Indiana University

Study Record Dates

2025-12-31